Target Company Overview
Suzhou Yilit Technology Co., Ltd. (hereinafter referred to as 'Yilit Technology') has recently completed its first round of financing, surpassing 100 million yuan. This round was led by Jifeng Capital and Suzhou High-tech Venture Capital, with participation from several investors including Guofa Venture Capital, Qiao Jing Capital, Lianxin Capital, Leibot Tech, and Qishi Dingfeng. Yilit Technology boasts over 30 years of experience in research and development (R&D) as well as transformation in the field of liquid chromatography instruments and related consumables, establishing itself as a leading domestic enterprise capable of independent research and volume production. As a pioneer in generating commercialized HPLC (High-Performance Liquid Chromatography) and chromatographic columns in China, Yilit has achieved a significant market share in the domestic HPLC sector, underpinned by the strategic utilization of more than a hundred core patents to secure independent intellectual property rights and local production.
Yilit Technology has played a key role in formulating national standards for liquid chromatography and has led the drafting of several HPLC national standards. This successful financing round reflects market confidence in Yilit's past achievements and recognition of its potential for future growth. The company is focused on developing a series of instruments and consumables for laboratory physical and chemical analysis, emerging biotechnology upstream purification, and clinical analytical diagnostics, emphasizing its commitment to the
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Similar Deals
Dingfeng BioCapital and Innovation Works → Heranova Lifesciences Holding
2023
Adicon Holdings Limited → Crown Bioscience Inc.
2026
济峰资本
invested in
依利特科技
in 2024
in a Seed Stage deal
Disclosed details
Transaction Size: $15M